Position
Renaissance Technologies in Century Therapeutics, Inc.
Back to the book · All holders of IPSC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $172.3K$2.26 → $2.45
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.35M | $1.34M | — | — | — | 0.0% |
| Q1 2026 | 906.8K | $2.05M | $2.26 | $1.15M | −$440.1K | 0.0% |
| Q2 2026 | 1.26M | $3.08M | $2.45 | $172.3K | $859.6K | 0.0% |